Trial
NCT00906035
The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Pennsylvania
Collaborators
Boehringer Ingelheim
Condition
Peripheral Arterial Disease
Intervention
Dipyridamole 200mg and Aspirin 25mg bid:
Why stopped
Could not enroll subjects who met the stringent inclusion/exclusion criteria.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-09-05